ClinicalTrials.gg
RecruitingNCT07851480CAUD-PINUpdated Oct 1, 2026

Validation of an Algorithm for Predicting Awakenings Associated With Trauma-related Nightmares, Based on the Analysis of Physiological Patterns in Military and Former Military Patients Suffering From Post-traumatic Stress Disorder

An interventional study of CAUD-PIN (CAUchemar Detection on INdividualized Parameters) - AI-based predictive algorithm forTrauma-related nightmare awakenings in PTSD - Post Traumatic Stress Disorder and Trauma-related Nightmares, sponsored by Direction Centrale du Service de Santé des Armées. Recruiting at 3 sites in France. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-10-01.

Sponsored by Direction Centrale du Service de Santé des Armées · Not applicable, Interventional, and Basic science

How we know

From the registry’s dates

  • Started Apr 2026; still recruiting 6 months later.
Updated Oct 1, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
27
Allocation
Not applicable
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 13 studies in Combat Disorders with a site in France — 7 open to participants now, 7 under way, 2 of them phase 3. Combat Disorders · France.

Planned enrollment
9th of 10
27 · median 70
Started
2026
with 4 others
No phase
7 of 13
4 open now
Registered
7th of 13
by date
Lead sponsor
1 of 13
Direction Centrale du Service de Santé des Armées

Among the 13 studies in Combat Disorders with a site in France, this one is the 9th largest by planned enrollment of the 10 interventional ones that give a count, is one of 5 that started in 2026, is one of 7 with no phase, and was the 7th registered.

Combat Disorders

204 studies on the registry are indexed under Combat Disorders; 93 are open to participants now.

Browse Combat Disorders studies →

Open to participants now

7 of the 13 studies in Combat Disorders with a site in France are open now. Recruiting first, the newest first:

1 more — sign in →

All 7 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 53 Combat Disorders studies recruiting now, 22 (42%) set no upper age limit and 26 (49%) stop at 75 or younger; 10 take children under 18; 5 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 13 studies in Combat Disorders with a site in France, or all of them as a file.
02

Study summary

The goal of this clinical trial is to validate an artificial intelligence algorithm called CAUD-PIN (CAUchemar Detection on INdividualized Parameters) to predict nightmare-related awakenings in military personnel and veterans suffering from post-traumatic stress disorder (PTSD). The main question it aim to answer is :

  • Can the CAUD-PIN algorithm detect physiological patterns preceding trauma-related nightmare awakenings with a sensitivity greater than 80%?
  • What physiological signals best predict the occurrence of a trauma-related nightmare awakening?

Participants will:

Wear two non-invasive devices at home - an EEG headband and a wrist-worn sensor bracelet - for 15 consecutive nights Press a button on the bracelet each time they wake up from a nightmare Complete sleep and daytime diaries every evening and morning Attend two clinical assessments (at enrollment and at the end of the study, one month later) at one of the three participating military hospitals

The algorithm will be applied to the recorded data after collection and does not intervene in real time or affect participants' standard medical care in any way.

03

Conditions studied

  • PTSD - Post Traumatic Stress Disorder
  • Trauma-related Nightmares

Keywords

  • Post-Traumatic Stress Disorder (PTSD)
  • Trauma-related nightmares
  • Sleep disorders
  • Artificial Intelligence
  • Machine Learning
  • Wearable Devices
  • Physiological Monitoring
  • Physiological signal processing
  • Sleep Recording
  • Military Personnel
  • Veterans
  • Ecological Momentary Assessment (EMA)
  • Predictive Algorithm
  • Translational Research
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age between 18 and 65 years (age limit related to military status)
  • Active military personnel or veterans
  • Receiving psychiatric care in a military hospital (HNIA Bégin, HNIA Percy, or HRIA Brest) for PTSD related to combat trauma (exposure to death or life-threatening situations)
  • PCL-5 score > 33
  • Written obtained
  • Trauma-related nightmares occurring ≥ 4 times per week

Exclusion criteria

Exclusion Criteria:

  • Pre-existing progressive psychiatric disorder prior to trauma (condition requiring long-term treatment > 1 year)
  • Sleep disorder affecting sleep architecture (obstructive sleep apnea syndrome, narcolepsy)
  • Neurological disorder (acute confusional state, severe traumatic brain injury) Inability to provide
  • Persons under legal protection measures (guardianship, curatorship, or equivalent judicial protection)
  • Persons not affiliated with a social security scheme
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
27 participants (estimated)

Study arms

  • Experimental
    CAUD-PIN Validation Group

    French Military personnel and/or veterans with PTSD wear two non-invasive wearable devices at home - an EEG headband (Hypnodyne Zmax Lite) and a multisensor bracelet (Empatica EmbracePlus) - for 15 consecutive nights. Participants press a button on the bracelet to report each nightmare-related awakening. Physiological data are analyzed post-hoc by the CAUD-PIN algorithm to validate its ability to predict trauma-related nightmare awakenings. Two clinical assessments are conducted at enrollment and at study completion.

    Diagnostic Test: CAUD-PIN (CAUchemar Detection on INdividualized Parameters) - AI-based predictive algorithm forTrauma-related nightmare awakenings

Interventions

  • Diagnostic testCAUD-PIN (CAUchemar Detection on INdividualized Parameters) - AI-based predictive algorithm forTrauma-related nightmare awakenings

    CAUD-PIN (CAUchemar Detection on INdividualized Parameters) is a non-invasive, AI-based predictive algorithm developed by the VIFASOM research team (UMR 7330, Université Paris Cité / French Military Health Service) from the SOMMEPT clinical project. It analyzes multimodal physiological signals recorded during home sleep to identify patterns preceding Trauma-related nightmare awakenings in military patients with PTSD. Data are collected using two wearable devices: an EEG headband (Hypnodyne Zmax Lite) measuring brain activity and sleep stages, and a wrist-worn multisensor bracelet (Empatica EmbracePlus) measuring heart rate, electrodermal activity, skin temperature, and motor activity. The algorithm is applied exclusively post-hoc to pseudonymized recordings, with no real-time intervention and no impact on participants' standard medical care.

06

What researchers measure

Primary outcomes

  1. Sensitivity of the CAUD-PIN algorithm in predicting Trauma-related nightmare awakenings

    Sensitivity will be calculated as the number of Trauma-related nightmare awakenings correctly identified by the CAUD-PIN algorithm divided by the total number of confirmed trauma-related nightmare awakenings, multiplied by 100. Unit of Measure: Percentage

    Time frame: During the 15 consecutive nights of home sleep recording

Secondary outcomes

  1. Specificity of the CAUD-PIN algorithm for predicting Trauma-related nightmare awakenings

    Specificity will be calculated as the number of events correctly classified as not being trauma-related nightmare awakenings divided by the total number of confirmed non-nightmare events, multiplied by 100. Unit of Measure: Percentage

    Time frame: During the 15 consecutive nights of home sleep recording

  2. Positive predictive value of the CAUD-PIN algorithm

    Positive predictive value will be calculated as the number of correctly predicted trauma-related nightmare awakenings divided by the total number of trauma-related nightmare awakenings predicted by the CAUD-PIN algorithm, multiplied by 100. Unit of Measure: Percentage

    Time frame: During the 15 consecutive nights of home sleep recording

  3. Negative predictive value of the CAUD-PIN algorithm

    Negative predictive value will be calculated as the number of events correctly predicted as not being trauma-related nightmare awakenings divided by the total number of events predicted as not being trauma-related nightmare awakenings, multiplied by 100. Unit of Measure: Percentage

    Time frame: During the 15 consecutive nights of home sleep recording

  4. Prediction lead time before trauma-related nightmare awakening

    Mean time (in seconds) between the physiological predictive pattern detected by the CAUD-PIN algorithm and the participant's button press indicating a trauma-related nightmare awakening. Unit of Measure: Seconds

    Time frame: Through 15 nights of recording

  5. Intra- and inter-individual variability in heart rate preceding trauma-related nightmare awakenings

    Intra- and inter-individual variability in heart rate (beats per minute, bpm) preceding trauma-related nightmare awakenings. Variability will be quantified using: * Within-subject standard deviation (SD) * Between-subject variance estimated using mixed-effects models

    Time frame: During the 15 consecutive nights of home sleep recording

  6. Intra- and inter-individual variability in electrodermal activity preceding trauma-related nightmare awakenings

    Intra- and inter-individual variability in electrodermal activity (microsiemens, µS) preceding trauma-related nightmare awakenings. Variability will be quantified using: * Within-subject standard deviation (SD) * Between-subject variance estimated using mixed-effects models

    Time frame: After completion of all participant data collection, following the 15-night recording period for each participant (approximately 18 months after study start)

  7. Intra- and inter-individual variability in skin temperature preceding trauma-related nightmare awakenings

    Intra- and inter-individual variability in skin temperature (°C) preceding trauma-related nightmare awakenings. Variability will be quantified using: * Within-subject standard deviation (SD) * Between-subject variance estimated using mixed-effects models

    Time frame: After completion of all participant data collection, following the 15-night recording period for each participant (approximately 18 months after study start)

  8. Intra- and inter-individual variability in motor activity preceding trauma-related nightmare awakenings

    Intra- and inter-individual variability in motor activity (activity counts) preceding trauma-related nightmare awakenings. Variability will be quantified using: * Within-subject standard deviation (SD) * Between-subject variance estimated using mixed-effects models

    Time frame: After completion of all participant data collection, following the 15-night recording period for each participant (approximately 18 months after study start)

  9. Area Under the Curve (AUC) of the CAUD-PIN algorithm on combined dataset

    Area Under the Receiver Operating Characteristic Curve (AUC, unitless) of the CAUD-PIN algorithm when trained and evaluated on the CAUD-PIN dataset alone compared to the combined dataset (SOMMEPT + CAUD-PIN).

    Time frame: After completion of all participant data collection, following the 15-night recording period for each participant (approximately 18 months after study start)

  10. F1-score of the CAUD-PIN algorithm on combined dataset

    F1-score (unitless) of the CAUD-PIN algorithm when trained and evaluated on the CAUD-PIN dataset alone compared to the combined dataset (SOMMEPT + CAUD-PIN).

    Time frame: After completion of all participant data collection, following the 15-night recording period for each participant (approximately 18 months after study start)

  11. Correlation between PCL-5 total score and percentage of trauma-related nightmare nights

    PTSD severity will be assessed at T1 using the PTSD Checklist for DSM-5 (PCL-5) total score, ranging from 0 to 80 points. Trauma-related nightmare frequency will be calculated as the percentage of valid recording nights containing at least one participant-confirmed trauma-related nightmare awakening. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).

    Time frame: At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording

  12. Correlation between Beck Depression Inventory total score and percentage of trauma-related nightmare nights

    Depression severity will be assessed at T1 using the Beck Depression Inventory (BDI) total score, ranging from 0 to 63 points. Trauma-related nightmare frequency will be calculated as the percentage of valid recording nights containing at least one participant-confirmed trauma-related nightmare awakening. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).

    Time frame: At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording

  13. Correlation between WHOQOL-BREF score and percentage of trauma-related nightmare nights

    Quality of life will be assessed at T1 using the World Health Organization Quality of Life-BREF (WHOQOL-BREF) \[specify total or domain score and range\]. Trauma-related nightmare frequency will be calculated as the percentage of valid recording nights containing at least one participant-confirmed trauma-related nightmare awakening. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).

    Time frame: At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording

  14. Correlation between Nightmare Severity Index score and percentage of trauma-related nightmare nights

    Nightmare severity will be assessed at T1 using the Nightmare Severity Index (NSI) total score. Trauma-related nightmare frequency will be calculated as the percentage of valid recording nights containing at least one participant-confirmed trauma-related nightmare awakening. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).

    Time frame: At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording

  15. Correlation between mean number of trauma-related nightmare awakenings per night and percentage of trauma-related nightmare nights

    The mean number of trauma-related nightmare awakenings per night will be calculated as the total number of participant-confirmed trauma-related nightmare awakenings divided by the number of valid recording nights. The percentage of trauma-related nightmare nights will be calculated as the percentage of valid recording nights containing at least one confirmed awakening. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).

    Time frame: During the 15 consecutive nights of home sleep recording

  16. Correlation between mean heart rate and percentage of trauma-related nightmare nights

    Heart rate will be measured in beats per minute using Empatica EmbracePLUS. For each participant, mean heart rate will be calculated across sleep period preceeding trauma-ralated awakeking across 15 nights. Trauma-related nightmare frequency will be calculated as the percentage of valid recording nights containing at least one participant-confirmed trauma-related nightmare awakening. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).

    Time frame: During the 15 consecutive nights of home sleep recording

  17. Correlation between mean electrodermal activity and percentage of trauma-related nightmare nights

    Electrodermal activity will be measured in microsiemens (µS) using Empatica EmbracePLUS. For each participant, mean electrodermal activity will be calculated across across sleep period preceeding trauma-ralated awakeking across across sleep period preceeding trauma-ralated awakeking across 15 nights. Trauma-related nightmare frequency will be calculated as the percentage of valid recording nights containing at least one participant-confirmed trauma-related nightmare awakening. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).

    Time frame: During the 15 consecutive nights of home sleep recording

  18. Correlation between mean skin temperature and percentage of trauma-related nightmare nights

    Skin temperature will be measured in degrees Celsius using Empatica EmbracePLUS. For each participant, mean skin temperature will be calculated across across sleep period preceeding trauma-ralated awakeking across 15 nights. Trauma-related nightmare frequency will be calculated as the percentage of valid recording nights containing at least one participant-confirmed trauma-related nightmare awakening. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).

    Time frame: During the 15 consecutive nights of home sleep recording

  19. Correlation between mean motor activity and percentage of trauma-related nightmare nights

    Motor activity will be measured in activity counts using Empatica EmbracePLUS. For each participant, mean motor activity will be calculated across across sleep period preceeding trauma-ralated awakeking across 15 nights. Trauma-related nightmare frequency will be calculated as the percentage of valid recording nights containing at least one participant-confirmed trauma-related nightmare awakening. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).

    Time frame: During the 15 consecutive nights of home sleep recording

  20. Correlation between trauma-related nightmare awakening frequency and change in PCL-5 total score between T1 and T2

    Trauma-related nightmare frequency will be calculated as the total number of participant-confirmed trauma-related nightmare awakenings divided by the number of valid recording nights, expressed as awakenings per night. PTSD severity will be assessed at T1 and T2 using the PCL-5 total score, ranging from 0 to 80 points. Change will be calculated as the difference between the PCL-5 total scores obtained at T1 and T2. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).

    Time frame: From Visit 1 (baseline) to Visit 2 (end of study, Day 30 ± 5 days after inclusion)

  21. Correlation between trauma-related nightmare awakening frequency and change in Beck Depression Inventory total score between T1 and T2

    Trauma-related nightmare frequency will be calculated as the total number of participant-confirmed trauma-related nightmare awakenings divided by the number of valid recording nights, expressed as awakenings per night. Depression severity will be assessed at T1 and T2 using the Beck Depression Inventory total score, ranging from 0 to 63 points. Change will be calculated as the difference between the BDI total scores obtained at T1 and T2. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).

    Time frame: From Visit 1 (baseline) to Visit 2 (end of study, Day 30 ± 5 days after inclusion)

  22. Correlation between trauma-related nightmare awakening frequency and change in WHOQOL-BREF score between T1 and T2

    Trauma-related nightmare frequency will be calculated as the total number of participant-confirmed trauma-related nightmare awakenings divided by the number of valid recording nights, expressed as awakenings per night. Quality of life will be assessed at T1 and T2 using the WHOQOL-BREF \[specify total or domain score and range\]. Change will be calculated as the difference between the WHOQOL-BREF scores obtained at T1 and T2. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).

    Time frame: From Visit 1 (baseline) to Visit 2 (end of study, Day 30 ± 5 days after inclusion)

  23. Correlation between PCL-5 total score at T1 and PSQI total score

    PTSD severity will be assessed at T1 using the PCL-5 total score, ranging from 0 to 80 points. Subjective sleep quality will be assessed using the Pittsburgh Sleep Quality Index (PSQI) total score, ranging from 0 to 21 points, with higher scores indicating poorer sleep quality. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).

    Time frame: At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording

  24. Correlation between PCL-5 total score at T1 and mean total sleep time

    PTSD severity will be assessed at T1 using the PCL-5 total score, ranging from 0 to 80 points. Total sleep time will be measured in minutes usingHypnodyne Zmax Lite device and PSQI questionnary and averaged across all valid recording nights. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).

    Time frame: At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording

  25. Correlation between PCL-5 total score at T1 and mean sleep efficiency

    PTSD severity will be assessed at T1 using the PCL-5 total score, ranging from 0 to 80 points. Sleep efficiency will be measured usingHypnodyne Zmax Lite device and PSQI questionnary, calculated as total sleep time divided by time in bed and multiplied by 100, and averaged across valid recording nights. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).

    Time frame: At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording

  26. Correlation between PCL-5 total score at T1 and mean wake after sleep onset

    PTSD severity will be assessed at T1 using the PCL-5 total score, ranging from 0 to 80 points. Wake after sleep onset will be measured in minutes using Hypnodyne Zmax Lite device and PSQI questionnary and averaged across all valid recording nights. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).

    Time frame: At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording

  27. Correlation between Beck Depression Inventory total score at T1 and PSQI total score

    Depression severity will be assessed at T1 using the Beck Depression Inventory total score, ranging from 0 to 63 points. Subjective sleep quality will be assessed using the PSQI total score, ranging from 0 to 21 points, with higher scores indicating poorer sleep quality. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).

    Time frame: At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording

  28. Correlation between Beck Depression Inventory total score at T1 and mean total sleep time

    Depression severity will be assessed at T1 using the Beck Depression Inventory total score, ranging from 0 to 63 points. Total sleep time will be measured in minutes using Hypnodyne Zmax Lite device and PSQI questionnary and averaged across all valid recording nights. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).

    Time frame: At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording

  29. Correlation between Beck Depression Inventory total score at T1 and mean sleep efficiency

    Depression severity will be assessed at T1 using the Beck Depression Inventory total score, ranging from 0 to 63 points. Sleep efficiency will be measured using Hypnodyne Zmax Lite device and PSQI questionnary, calculated as total sleep time divided by time in bed and multiplied by 100, and averaged across valid recording nights. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).

    Time frame: At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording

  30. Correlation between Beck Depression Inventory total score at T1 and mean wake after sleep onset

    Depression severity will be assessed at T1 using the Beck Depression Inventory total score, ranging from 0 to 63 points. Wake after sleep onset will be measured in minutes using using Hypnodyne Zmax Lite device and PSQI questionnary and averaged across all valid recording nights. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).

    Time frame: At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording

  31. Correlation between Nightmare Severity Index score at T1 and PSQI total score

    Nightmare severity will be assessed at T1 using the Nightmare Severity Index total score.. Subjective sleep quality will be assessed using the PSQI total score, ranging from 0 to 21 points, with higher scores indicating poorer sleep quality. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).

    Time frame: At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording

  32. Correlation between Nightmare Severity Index score at T1 and mean total sleep time

    Nightmare severity will be assessed at T1 using the Nightmare Severity Index total score.. Total sleep time will be measured in minutes using Hypnodyne Zmax Lite and PSQI questionnary and averaged across all valid recording nights. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).

    Time frame: At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording

  33. Correlation between Nightmare Severity Index score at T1 and mean sleep efficiency

    Nightmare severity will be assessed at T1 using the Nightmare Severity Index total score.. Sleep efficiency will be measured using Hypnodyne Zmax Lite and PSQI questionnary, calculated as total sleep time divided by time in bed and multiplied by 100, and averaged across valid recording nights. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).

    Time frame: At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording

  34. Correlation between Nightmare Severity Index score at T1 and mean wake after sleep onset

    Nightmare severity will be assessed at T1 using the Nightmare Severity Index total score.. Wake after sleep onset will be measured in minutes using Hypnodyne Zmax Lite and PSQI questionnary and averaged across all valid recording nights. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).

    Time frame: At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording

07

Study locations

2 of 3 sites recruiting
  • Clermont Tonnerre Regional Military Teaching Hospital, psychiatry department
    Brest, 29200, France
    Recruiting
    • Julia SALOMÉ, MD, PHD · Contact
  • Percy National Military Teaching Hospital, Department of Psychiatry
    Clamart, 92190, France
    Not yet recruiting
    • Gilles SIPAHIMALANI, MD, PhD · Contact
  • Bégin National Military Teaching Hospital
    Saint-Mandé, Île-de-France Region 94160, France
    Recruiting
08

References and documents

Publications

  • Feingold D, Roseau JB, Verdonk C, Richards A, Chennaoui M, Saguin E, Leger D. Trauma-related nightmares: A Comprehensive and Integrative review. Sleep Med Rev. 2026 Jun;87:102259. doi: 10.1016/j.smrv.2026.102259. Epub 2026 Feb 18. PubMed 41886932 ↗
  • Feingold D, Quiquempoix M, Remadi M, Sipahimalani G, Lahutte B, Leger D, Gomez-Merino D, Chennaoui M, Saguin E. Physiological markers of Trauma-related nightmares among military personnel suffering from PTSD: A multicenter home-recording study. Psychiatry Clin Neurosci. 2026 May;80(5):398-408. doi: 10.1111/pcn.70038. Epub 2026 Feb 14. PubMed 41689450 ↗
  • Saguin E, Feingold D, Sipahimalani G, Quiquempoix M, Roseau JB, Remadi M, Annette S, Guillard M, Van Beers P, Lahutte B, Leger D, Gomez-Merino D, Chennaoui M. PTSD Symptom Severity Associated With Sleep Disturbances in Military Personnel: Evidence From a Prospective Controlled Study With Ecological Recordings. Depress Anxiety. 2025 Apr 25;2025:8011375. doi: 10.1155/da/8011375. eCollection 2025. PubMed 40370761 ↗
  • Saguin E, Feingold D, Roseau JB, Quiquempoix M, Boussaud M, Izabelle C, Metlaine A, Guillard M, Van Beers P, Gheorghiev C, Lahutte B, Leger D, Gomez-Merino D, Chennaoui M. An ecological approach to clinically assess nightmares in military service members with severe PTSD. Sleep Med. 2023 Mar;103:78-88. doi: 10.1016/j.sleep.2023.01.024. Epub 2023 Jan 28. PubMed 36764045 ↗

Individual participant data

Plan to share: No — Individual participant data will not be shared. This study involves military personnel and veterans with PTSD, whose physiological and psychological data are considered highly sensitive. Data are pseudonymized and managed in accordance with the French General Data Protection Regulation (GDPR, EU 2016/679) and the Reference Methodology MR-001. Access is restricted to authorized members of the research team. Only aggregated and de-identified results will be disseminated through scientific publications and conference presentations.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2026 (actual). Primary completion is estimated for Oct 2027, 18 months after the start.

Of 76 non-industry interventional studies with no phase under Combat Disorders, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 44. This study's planned 18 months is below that.

Counting every sponsor, half of 82 studies reached it within 25 months; a quarter within 12 and three quarters within 44.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 2, 2026
First posted
Oct 1, 2026
StartActual
Apr 30, 2026
Primary completionEst.
Oct 2027
CompletionEst.
Oct 2027
Last update
Oct 1, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 1, 2026
Show all 1 update
  1. Oct 1, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07851480
Lead sponsor
Direction Centrale du Service de Santé des Armées
Responsible party
Sponsor
First posted
Oct 1, 2026
Start date
Apr 30, 2026
Primary completion
Oct 2027 (estimated)
Completion
Oct 2027 (estimated)
Last update
Oct 1, 2026

Study contacts

Emeric SAGUIN, MD, PhD
Contact
emeric.saguin@intradef.gouv.fr
+33 01 43 98 54 40
Dorone FEINGOLD, Msc
Contact
dorone.feingold@gmail.com
+33 6 51 11 19 56
Emeric SAGUIN, MD, PhD
principal investigator · Department of Psychiatry, Begin National Military Teaching Hospital, Saint-Mandé, 94160, France

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion